A heterozygous variant in the SLC22A12 gene in a Sri Lanka family associated with mild renal hypouricemia

. 2018 Jun 29 ; 18 (1) : 210. [epub] 20180629

Jazyk angličtina Země Anglie, Velká Británie Médium electronic

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid29958533
Odkazy

PubMed 29958533
PubMed Central PMC6025733
DOI 10.1186/s12887-018-1185-9
PII: 10.1186/s12887-018-1185-9
Knihovny.cz E-zdroje

BACKGROUND: Renal hypouricemia is a rare heterogeneous inherited disorder characterized by impaired tubular uric acid transport, reabsorption insufficiency and /or acceleration of secretion. The affected individuals are predisposed to nephrolithiasis and recurrent episodes of exercise-induced acute kidney injury. Type 1 is caused by dysfunctional variants in the SLC22A12 gene (URAT1), while type 2 is caused by defects in the SLC2A9 gene (GLUT9). To date, more than 150 patients with the loss-of-function mutations for the SLC22A12 gene have been found (compound heterozygotes and/or homozygotes), most of whom are Japanese and Koreans. CASE PRESENTATION: Herein, we report a nine year old Sri Lankan boy with renal hypouricemia (serum uric acid 97 μmol/L, fractional excretion of uric acid 33%).The sequencing analysis of SLC22A12 revealed a potentially deleterious missense variant c.1400C > T (p.T467 M, rs200104135) in heterozygous state. This variant has been previously identified in homozygous and/or compound heterozygous state with other causative SLC22A12 variant c.1245_1253del (p.L415_G417del) in Roma population. CONCLUSIONS: This is the first identification of a family with mild renal hypouricemia1 associated to the p.T467 M variant. Detailed investigations of urate blood and urine concentrations in patients with unexplained hypouricemia are needed and renal hypouricemia should also be considered in patients other than those from Japan and/or Korea. Our finding confirms an uneven geographical and ethnic distribution of Romany prevalent SLC22A12 variant that need to be considered in Asian patients (population data Genome Aggregation Database: allele frequency in South Asia 0.007055, in East Asia 0.001330).

Zobrazit více v PubMed

Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature. 2002;417:447–452. doi: 10.1038/nature742. PubMed DOI

Dinour D, Gray NK, Campbell S, Shu X, Sawyer L, Richardson W, et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. JASN. 2010;21:64–72. doi: 10.1681/ASN.2009040406. PubMed DOI PMC

Shima Y, Nozu K, Nozu Y, Togawa H, Kaito H, Matsuo M, et al. Recurrent EIARF and PRES with severe renal hypouricemia by compound heterozygous SLC2A9 mutation. Pediatrics. 2011;127:e1621–e1625. doi: 10.1542/peds.2010-2592. PubMed DOI

Sebesta I, Stiburkova B, Bartl J, Ichida K, Hosoyamada M, Taylor J, et al. A.Diagnostic tests for primary renal hypouricemia. Nucleosides Nucleotides Nucleic Acids. 2011;30:1112–1116. doi: 10.1080/15257770.2011.611483. PubMed DOI

Stiburkova B, Sebesta I, Ichida K, Nakamura M, Hulkova H, Krylov V, et al. Novel allelic variants and evidence for a prevalent mutation in URAT1 causing renal hypouricemia: biochemical, genetics and functional analysis. EJHG. 2013;21:1067–1073. doi: 10.1038/ejhg.2013.3. PubMed DOI PMC

Mancikova A, Krylov V, Hurba O, Sebesta I, Nakamura M, Ichida K, et al. Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2. Clin Exp Nephrol. 2016;20:578–584. doi: 10.1007/s10157-015-1186-z. PubMed DOI

Bhasin B, Stiburkova B, De Castro-Pretelt M, Beck N, Bodurtha JN, Atta MG. Hereditary renal hypouricemia: a new rolefor allopurinol? Am J Med. 2014;127:e3–e4. doi: 10.1016/j.amjmed.2013.08.025. PubMed DOI

Stiburkova B, Ichida K, Sebesta I. Novel homozygous insertion in SLC2A9 gene caused renal hypouricemia. Mol Genet Metab. 2011;102:430–435. doi: 10.1016/j.ymgme.2010.12.016. PubMed DOI

Hurba O, Mancikova A, Krylov V, Pavlikova M, Pavelka K, Stiburkova B. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout. PLoS One. 2014;9:e107902. doi: 10.1371/journal.pone.0107902. PubMed DOI PMC

Gabrikova D, Bernasovska J, Sokolova J, Stiburkova B. High frequency of SLC22A12 variants causing renal hypouricemia 1 in the Czech and Slovak Roma population; simple and rapid detection method by allele-specific polymerase chain reaction. Urolithiasis. 2015;43:441–445. doi: 10.1007/s00240-015-0790-4. PubMed DOI

Stiburkova B, Gabrikova D, Čepek P, Šimek P, Kristian P, Cordoba-Lanus E, et al. Prevalence of URAT1 allelic variants in the Roma population. Nucleosides Nucleotides Nucleic Acids. 2016;35:529–535. doi: 10.1080/15257770.2016.1168839. PubMed DOI

Claverie-Martin F, Trujillo-Suarez J, Gonzalez-Acosta H, Aparicio C, Justa Roldan ML, Stiburkova B, et al. URAT1 and GLUT9 mutations in Spanish patients with renal hypouricemia. Clin Chim Acta. 2018;481:83–89. doi: 10.1016/j.cca.2018.02.030. PubMed DOI

Iwai N, Mino Y, Hosoyamada M, Tago N, Kokubo Y, Endou H. A high prevalence of Renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int. 2004;66:935–944. doi: 10.1111/j.1523-1755.2004.00839.x. PubMed DOI

Tabara Y, Kohara K, Kawamoto R, Hiura Y, Nishimura K, Morisaki T, et al. Association of four genetic loci with uric acid levelsand reduced renal function: the J-SHIPP Suita study. Am J Nephrol. 2010;32:279–286. doi: 10.1159/000318943. PubMed DOI

Anzai N, Kanai Y, Endou H. New insights into renal transport of urate. CurrOpin Rheumatol. 2007;19:151–157. PubMed

Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372:1953–1961. doi: 10.1016/S0140-6736(08)61343-4. PubMed DOI PMC

Karns R, Zhang G, Sun G, Indugula SR, Cheng H, Havas-Augustin D, et al. Genome wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia. Ann Hum Genet. 2012;76:121–127. doi: 10.1111/j.1469-1809.2011.00698.x. PubMed DOI PMC

Li S, Sanna S, Maschio A, Busonero F, Usala G, Mulas A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and chianti cohorts. PLoS Genet. 2007;3:e194. doi: 10.1371/journal.pgen.0030194. PubMed DOI PMC

Ichida K, Hosoyamada M, Hisatome I, Enomoto A, Hikita M, Endou H, et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol. 2004;15:164–173. doi: 10.1097/01.ASN.0000105320.04395.D0. PubMed DOI

Gresham D, Morar B, Underhill PA, Passarino G, Lin AA, Wise C, et al. Origins and divergence of the Roma (gypsies) Am J Hum Genet. 2001;69:1314–1331. doi: 10.1086/324681. PubMed DOI PMC

Morar B, Gresham D, Angelicheva D, Tournev I, Gooding R, Guergueltcheva V, et al. Mutation history of theroma/gypsies. Am J Hum Genet. 2004;75:596–609. doi: 10.1086/424759. PubMed DOI PMC

Li Z, Ding H, Chen CH, Chen Y, Wang DW, Lv Y. Novel URAT1 mutations caused acute renal failure after exercise in two Chinese families with renal hypouricemia. Gene. 2013;512:97–101. doi: 10.1016/j.gene.2012.09.115. PubMed DOI

Stiburkova B, Stekrova J, Nakamura M, Ichida K. Hereditary renal Hypouricemia type 1 and autosomal dominant polycystic kidney disease. Am J Med Sci. 2015;350:268–271. doi: 10.1097/MAJ.0000000000000550. PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace